Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production.
about
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen speciesCD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow nicheThe evolution within usmicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cellsIncorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.Interplays between mouse mammary tumor virus and the cellular and humoral immune response.Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor.Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.B-cell memory and the persistence of antibody responses.In vivo maturation and migration of dendritic cells.Regulation of Th1 and Th2 immune responses by chemokines.Extrafollicular antibody responses.The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.Homing of antibody secreting cells.On the dynamics of T-cell activation in lymph nodes.A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.Regulation of lymph node vascular growth by dendritic cells.Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival.A coordinated change in chemokine responsiveness guides plasma cell movementsIn vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokinesGerminal centers without T cellsIn vivo detection of dendritic cell antigen presentation to CD4(+) T cells.Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switchingA novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells.Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spread.Characterization of T-Dependent and T-Independent B Cell Responses to a Virus-like Particle.The changing preference of T and B cells for partners as T-dependent antibody responses develop.Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes.Development of T-B cell collaboration in neonatal mice.Loss of CD154 impairs the Th2 extrafollicular plasma cell response but not early T cell proliferation and interleukin-4 induction.Pinpointing IL-4-independent acquisition and IL-4-influenced maintenance of Th2 activity by CD4 T cells.Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi.Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.CCR7-deficient mice develop atypically persistent germinal centers in response to thymus-independent type 2 antigens.
P2860
Q24632831-9234ACBF-A07D-41EB-9B61-3FA74AC022AAQ24657562-94A4FAB9-7E5D-4F2A-AFFF-D165AA97C8C2Q26801603-B3E07612-32AE-48A5-ACEE-8DEC0F9094FBQ29619307-3EECD827-E583-4D13-B37A-BD76CF022ABAQ30372024-D6145AB6-1C05-4095-9375-5C4FAB3AFCD1Q33683433-17BAEECF-8536-4CF1-AD3E-DF4A2FA4302EQ33782976-1F2E7E01-4FCD-4858-A2AF-1EDD840D4107Q33820167-ADD0DE3C-843D-42F8-90C6-77A6B6362C3DQ33905208-1FBF3374-5FF9-4318-8132-A7D706C22F3BQ33942185-83279E42-E92C-4545-A899-E24F5902C04DQ34129739-A4348C1D-92AE-4CB8-BD29-7C9804949CF8Q34212117-6DD24D1C-0ECD-40E6-B3AD-1103A118A8A4Q34467281-53DE1FA9-4EE7-46B8-93C8-05F3F25BB2D2Q35170914-CC10BFE5-0437-445C-95F0-3E24EC2D7ED3Q35675895-7075E938-9C64-4ABA-B096-636529A5002BQ35895053-6BDA7290-8A77-45F8-900F-F5C19128A7A6Q36228770-338467F2-AD40-4905-AD2C-B1F3772C6CB8Q36368882-5D50A4A9-7F8D-4EF9-830D-373D9F6D3ABBQ36369352-EE402EBC-BC43-4E3B-AFDC-3F773B7730D9Q36375434-E74F25BA-E382-49AB-9AEE-F643AB378A3DQ36375933-EA4CC6D4-C298-4150-A0F2-5530B8AB82B2Q36377341-DB0F843D-48C5-46D0-AE49-91C6EC1E40CEQ36380500-0A2741B2-1A7B-44F1-AAB4-4984E4C65486Q36400665-E89EA5A3-AA0A-4633-B8B0-8BB800EDDE8BQ36424177-CB2E6630-02E0-4B60-9BC8-1B469EA2EED4Q36445623-73E333D9-0B59-4BEA-9375-81710D1B2AC6Q38675682-B11DCDC5-CB04-4028-AAD1-A39251CF9804Q39605511-17597799-9B8C-44AC-BD44-6C2EAA991B77Q40239470-F51D1CCD-F85B-4617-AB20-9A61AB411728Q41492213-1FE9AEF5-094D-4D77-9B44-D182B1837D59Q42088119-F246E9D6-8CBA-4163-B892-CC92FEEFE788Q43480685-3DF55FB7-37A0-428C-B623-3A2011FCEEA4Q45067678-9C8B34E2-50F3-4DD7-B263-A0F305A50529Q46907814-B559AF30-59D3-4355-8F40-FECDD32D5575Q47841563-5FB7B38A-E9B3-46D5-87F9-9B88D6CF83A9Q50559773-949AFF29-5C3F-4DE8-A5F8-EC48BB58BDCFQ51960015-33F8DF0E-8DD5-44A0-86C0-AA0F018156E3
P2860
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Viral superantigen drives extr ...... -specific antibody production.
@ast
Viral superantigen drives extr ...... -specific antibody production.
@en
type
label
Viral superantigen drives extr ...... -specific antibody production.
@ast
Viral superantigen drives extr ...... -specific antibody production.
@en
prefLabel
Viral superantigen drives extr ...... -specific antibody production.
@ast
Viral superantigen drives extr ...... -specific antibody production.
@en
P2093
P2860
P356
P1476
Viral superantigen drives extr ...... -specific antibody production.
@en
P2093
Acha-Orbea H
Gulbranson-Judge A
MacLennan IC
P2860
P304
P356
10.1084/JEM.185.3.551
P407
P577
1997-02-01T00:00:00Z